Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy

AF Abdel-Wahab, W Mahmoud, RM Al-Harizy - Pharmacological research, 2019 - Elsevier
Most solid tumor cells adapt to their heterogeneous microenvironment by depending largely
on aerobic glycolysis for energy production, a phenomenon called the Warburg effect, which …

Targeting glucose metabolism to overcome resistance to anticancer chemotherapy in breast cancer

E Varghese, SM Samuel, A Líšková, M Samec… - Cancers, 2020 - mdpi.com
Breast cancer (BC) is the most prevalent cancer in women. BC is heterogeneous, with
distinct phenotypical and morphological characteristics. These are based on their gene …

[HTML][HTML] Mitochondria and cancer chemoresistance

F Guerra, AA Arbini, L Moro - Biochimica et Biophysica Acta (BBA) …, 2017 - Elsevier
Mitochondria, known for more than a century as the energy powerhouse of a cell, represent
key intracellular signaling hub that are emerging as important determinants of several …

Targeting glucose metabolism enzymes in cancer treatment: current and emerging strategies

Y Zhang, Q Li, Z Huang, B Li, EC Nice, C Huang, L Wei… - Cancers, 2022 - mdpi.com
Simple Summary Reprogramming of glucose metabolism is a hallmark of cancer and can be
targeted by therapeutic agents. Some metabolism regulators, such as ivosidenib and …

Mechanism of antineoplastic activity of lonidamine

K Nath, L Guo, B Nancolas, DS Nelson… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Lonidamine (LND) was initially introduced as an antispermatogenic agent. It was later found
to have anticancer activity sensitizing tumors to chemo-, radio-, and photodynamic-therapy …

Cancer cell metabolic plasticity in migration and metastasis

JA Mosier, SC Schwager, DA Boyajian… - Clinical & experimental …, 2021 - Springer
Metabolic reprogramming is a hallmark of cancer metastasis in which cancer cells
manipulate their metabolic profile to meet the dynamic energetic requirements of the tumor …

Targeting the Akt/PI3K signaling pathway as a potential therapeutic strategy for the treatment of pancreatic cancer

S Ebrahimi, M Hosseini, S Shahidsales… - Current medicinal …, 2017 - ingentaconnect.com
The phosphoinositide 3 kinase AKT mammalian target of rapamycin (PI3K-AKTmTOR)
signaling pathway is an important in the aetiology of pancreatic cancer (PC) and is …

Mitochondrion as a novel target of anticancer chemotherapy

P Costantini, E Jacotot, D Decaudin… - Journal of the National …, 2000 - academic.oup.com
Mitochondrial membrane permeabilization is a critical event in the process leading to
physiologic or chemotherapy-induced apoptosis (programmed cell death). This …

Apoptosis: mechanisms and relevance in cancer

K Vermeulen, DR Van Bockstaele, ZN Berneman - Annals of hematology, 2005 - Springer
Apoptosis or programmed cell death is a process with typical morphological characteristics
including plasma membrane blebbing, cell shrinkage, chromatin condensation and …

Overview of cancer metabolism and signaling transduction

HS Chae, ST Hong - International Journal of Molecular Sciences, 2022 - mdpi.com
Despite the remarkable progress in cancer treatment up to now, we are still far from
conquering the disease. The most substantial change after the malignant transformation of …